Sensei Biotherapeutics, Inc. (SNSE) — SC 13D/A Filings
All SC 13D/A filings from Sensei Biotherapeutics, Inc.. Browse 2 SC 13D/A reports with AI-powered summaries and risk analysis.
SC 13D/A Filings (2)
-
Newtyn Management Amends Sensei Biotherapeutics Stake
— Mar 7, 2024 Risk: medium
Newtyn Management, LLC, a significant shareholder, filed an amendment (Amendment No. 2) to its Schedule 13D on March 7, 2024, regarding its holdings in Sensei B -
Newtyn Management Amends Sensei Biotherapeutics Stake
— Feb 13, 2024 Risk: low
Newtyn Management, LLC filed an Amendment No. 1 to its Schedule 13D on February 13, 2024, concerning its ownership in Sensei Biotherapeutics, Inc. The event req
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX